Idera Pharmaceuticals, Inc. (IDRA) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
08K15K22K30K38K45K52K60KQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
08K15K22K30K38K45K52K60KQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
04M8M11M15M19M22M26M30MQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

EBITDA

EBITDA
-30M-26M-22M-19M-15M-11M-7M-4M1Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

EPS

Revenue Variation (%)

Revenue Variation
-300-262-225-187-150-112-74-371Q4 2022Q1 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
03875112150188225262300Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Revenue YoY Variation (%)

Income YoY Variation (%)

Operating Income YoY VariationNet Income YoY Variation
01252503755006257508751KQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Price-to-Earning Ratio

P/E Ratio
-1-1-0-000011Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
050K100K150K200K250K300K350K400KQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Expense Ratios

Research And Ddevelopement To Revenue
0510152025303540Q1 2022Q2 2022Q3 2022Q4 2022Q1 2023
💰 Cash Flow Statement

Operating Cash Flow

Free Cash Flow

Cash At End Of Period
05M10M15M20M25M30M35M40MQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
05K10K15K20K25K30K35K40KQ1 2022Q2 2022Q3 2022Q4 2022Q1 2023
🏦 Balance Sheet
📈 Key Metrics